Measurement property | Patient population applied and measure extracted | ||
---|---|---|---|
MNA | SGA | PG-SGA | |
Diagnostic accuracy | Geriatric patients [36]: | End-stage renal failure [37]: | Post-appendectomy surgery [38]: |
− ROC = 0.85 ± 0.05 (95% CI 0.75 to 0.96, p < 0.0001); sensitivity: 83.30%; specificity: 74.40% | − SGA-C can discriminate patients who are not malnourished (specificity: 0.93-0.94), but cannot accurately identify patients with severe malnutrition (sensitivity: 0.05-0.14) | − Cut-off score = 7 | |
 | − ROC = 0.98; sensitivity: 88.60%; specificity: 100% | ||
Parkinson’s disease [33]: | Gynecological cancer [39]: | ||
− Cut-off score = 22.5 | − SGA-B is not accurate enough to identify mild-moderate malnutrition (specificity: 0.61–0.65; sensitivity: 0.68–0.59) | − ROC = 0.92 (95% CI, 0.84 to 1.01, p < 0.001) | |
− ROC =0.71 (p < 0.001); sensitivity: 58%; specificity: 82% | |||
Pre-frail elderly [34]: | Cancer inpatient [35]: | ||
− Cut-off score = 25.5 | − Cut-off score = 9 | ||
− ROC = 0.83 (95% CI 0.79 to 0.87); sensitivity: 72.10%; specificity: 91.20% | − sensitivity: 98%; specificity: 82% | ||
Frail elderly [34]: | |||
− Cut-off score = 25.5 | |||
− ROC = 0.90 (95% CI 0.88 to 0.93); sensitivity: 72.10%; specificity: 91.20% | |||
Test-retest reliability | Stroke [32]: | None | Palliation [40]: |
− ICC = 0.91 (95% C, 0.84 to 8.94) | − r = 0.87 | ||
Internal consistency | Parkinson’s disease [33]: | None | Hemodialysis [41] |
− Cronbach’s α = 0.70 (95% CI, 0.62 to 0.77) | − Cronbach’s α = 0.73 | ||
Geriatric patients [34]: | Palliation [40]: | ||
− Cronbach’s α = 0.70 | − Cronbach’s α = 0.72 | ||
Inter-rater reliability | None | General medicine [42]: | None |
Patients rated by two dietitians (Cohen’s kappa = 0.96, p < 0.001) versus dietitian and a trained allied health assistance (Cohen kappa = 0.84, p < 0.001) | |||
Gynecological cancer [43]: | |||
Patients rated by dietitian and nurse (Cohen’s kappa = 0.82) | |||
End-stage renal failure [37]: | |||
Patient rated by two dietitians (Cohen’s kappa = 0.79, 95% CI 0.67 to 0.92) versus dietitian and nephrologist (Cohen kappa = 0.60) | |||
Construct validity | Dialysis [44]: | Digestive disease [45]: | Patient with cancer had undergone radiation treatment [46]: |
Moderately correlated with a female’s body weight (r = 0.64) and BMI (r = 0.62) | Weak correlation with BMI (r = − 0.36), percentage of arm muscle circumference (r = − 0.33), percentage of triceps skin fold thickness (r = − 0.26), albumin (r = − 0.41), total cholesterol (r = − 0.16), and lymphocyte count (r = − 0.24). | ||
Moderately correlated with percentage weight loss (r = 0.53), global quality of life at the baseline (r = − 0.66), and after 4 weeks of radiotherapy (r = − 0.61) | |||
Live failure [47]: | |||
Moderately correlated with hand grip strength (r = 0.63) and albumin (r = 0.55) | |||
Cancer inpatient [35]: | |||
Cancer [48]: | Mild correlation with weight loss in the past 6 months (r = 0.56) | ||
Highly correlated with PG-SGA at the baseline (r = − 0.76), at the 4–6 weeks follow up (r = − 0.73) and at the 8–12 weeks follow up (r = − 0.83). | |||
Hemodialysis [41]: | |||
Moderately correlated with percentage weight loss in the past 6 months (r = 0.56) | |||
Parkinson’s disease [33]: | |||
Mildly correlated with weight (r = 0.43), BMI (r = 0.35), mid-arm circumference (r = 0.268), calf circumference (r = 0.29) | |||
Stroke [32]:Mildly correlated with quality of life (r = 0.32) | |||
Predictive validity | Dialysis [44]: | Digestive disease [45]: | Cancer inpatient [35]: |
Moderately correlated with the duration of dialysis (r = − 0.53) | Weak correlation with the length of hospital stays (r = 0.29) | Weak correlation with the length of stays (r = 0.36) | |
Post-appendectomy surgery [38]: | |||
Weak predictive validity for the length of stays (r = 0.38) | |||
Responsiveness to change and minimal detectable change (MDC) | Stroke [32]: | None | Patient with cancer had undergone radiotherapy [46]: |
MDC = 2.1 | a moderate correlation between the change in PG-SGA score and change in global quality of life after 4 weeks of radiotherapy (r = − 0.55) |